Department of Medical Sciences, Uppsala University, Box 256, 751 05 Uppsala, Sweden.
Trends Pharmacol Sci. 2010 Nov;31(11):509-15. doi: 10.1016/j.tips.2010.08.002. Epub 2010 Sep 16.
The emerging problem of antibiotic resistance is a serious threat to global public health. The situation is aggravated by a substantial decline in the research and development of antibacterial agents. Hence, very few new antibacterial classes are brought to market when older classes lose their efficacy. There has been renewed and growing attention within policy groups to: (i) address the problem; (ii) discuss incentives for the development of urgently needed new treatments; (iii) preserve the efficacy of existing therapeutic options. We briefly review the basic principles of antibiotic resistance, and contrast the increasing resistance to the dwindling antibacterial 'pipeline'. We also highlight some recent policy initiatives aiming to secure the future need of effective antibiotics.
抗生素耐药性这一新兴问题对全球公共健康构成了严重威胁。抗菌药物研发的大幅减少使情况更加恶化。因此,当旧的抗菌药物失去疗效时,很少有新的抗菌药物问世。政策制定者越来越关注:(i)解决这个问题;(ii)讨论开发急需新疗法的激励措施;(iii)保持现有治疗方法的疗效。我们简要回顾了抗生素耐药性的基本原则,并对比了日益增加的耐药性与日渐减少的抗菌“药物管”。我们还强调了一些旨在确保未来有效抗生素需求的最新政策举措。